Les soins infirmiers en oncologie au 21e siècle : voir le cancer comme une maladie chronique

Edith Pituskin

Abstract


Environ la moitié des Nord-Américains recevront un diagnostic de cancer au cours de leur vie lifetimes (Brenner et al., 2020). Grâce à l’amélioration des méthodes de dépistage et des traitements, le nombre de survivants du cancer connaît une croissance exponentielle. D’ici 2022, on s’attend à ce qu’il atteigne les 18 millions aux États-Unis (Henley et al., 2020). Selon des données recueillies en 2014, on estime que 63 % de la population canadienne ayant un cancer survivra 5 ans ou plus, comparativement à 55 % au début des années 1990, et à 25 %, dans les années 1940 (Brenner et al., 2020). On considère généralement comme survivant du cancer un patient ayant terminé un traitement à visée curative qui ne reçoit plus que des soins axés sur le suivi, la prévention des effets indésirables liés au traitement et des traitements d’entretien (ex. endocrinothérapie) (Medicine & Council, 2006). Cependant, un nouveau groupe de survivants est apparu dans les dix dernières années : celui des personnes qui vivent des années durant avec un cancer incurable grâce à un traitement continu.


Full Text:

PDF

References


Berry, L. L., Dalwadi, S. M., & Jacobson, J. O. (2017). Supporting the supporters: What family caregivers need to care for a loved one with cancer. Journal of Oncology Practice, 13(1), 35-41. https://doi.org/10.1200/jop.2016.017913

Bethune, G., Bethune, D., Ridgway, N., & Xu, Z. (2010). Epidermal growth factor receptor (EGFR) in lung cancer: An overview and update. Journal of thoracic disease, 2(1), 48-51. https://pubmed.ncbi.nlm.nih.gov/22263017

Booker, R., Bays, S., Burnett, L., & Torchetti, T. (2021). Supporting people and their caregivers living with advanced cancer: From individual experience to a National Interdisciplinary Program. Semin Oncol Nurs, 37(4), 151169. https://doi.org/10.1016/j.soncn.2021.151169

Brenner, D. R., Weir, H. K., Demers, A. A., Ellison, L. F., Louzado, C., Shaw, A., Turner, D., Woods, R. R., Smith, L. M., & Canadian Cancer Statistics Advisory, C. (2020). Projected estimates of cancer in Canada in 2020. CMAJ, 192(9), E199-E205. https://doi.org/10.1503/cmaj.191292

Brown, J. R., Moslehi, J., O’Brien, S., Ghia, P., Hillmen, P., Cymbalista, F., Shanafelt, T. D., Fraser, G., Rule, S., Kipps, T. J., Coutre, S., Dilhuydy, M. S., Cramer, P., Tedeschi, A., Jaeger, U., Dreyling, M., Byrd, J. C., Howes, A., Todd, M., Vermeulen, J., James, D. F., Clow, F., Styles, L., Valentino, R., Wildgust, M., Mahler, M., & Burger, J. A. (2017). Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials. Haematologica, 102(10), 1796-1805. https://doi.org/10.3324/haematol.2017.171041

Bultz, B. D., & Johansen, C. (2011). Screening for Distress, the 6th Vital Sign: Where are we, and where are we going? Psycho-Oncology, 20(6), 569-571. https://doi.org/https://doi.org/10.1002/pon.1986

Burger, J. A. (2019). Bruton Tyrosine Kinase Inhibitors: Present and future. Cancer journal (Sudbury, Mass.), 25(6), 386-393. https://doi.org/10.1097/PPO.0000000000000412

Burger, J. A., Barr, P. M., Robak, T., Owen, C., Ghia, P., Tedeschi, A., Bairey, O., Hillmen, P., Coutre, S. E., Devereux, S., Grosicki, S., McCarthy, H., Simpson, D., Offner, F., Moreno, C., Dai, S., Lal, I., Dean, J. P., & Kipps, T. J. (2020). Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: Five years of follow-up from the phase 3 RESONATE-2 study. Leukemia, 34(3), 787-798. https://doi.org/10.1038/s41375-019-0602-x

Carr, T., Arcand, L., Roberts, R., Sedgewick, J., Ali, A., & Groot, G. (2020). The experiences of Indigenous people with cancer in Saskatchewan: A patient-oriented qualitative study using a sharing circle. CMAJ open, 8(4), E852-E859. https://doi.org/10.9778/cmajo.20200012

Cummings, G. G., Lee, S. D., & Tate, K. C. (2018). The evolution of oncology nursing: Leading the path to change. Can Oncol Nurs J, 28(4), 314-317.

Dans, M., Kutner, J. S., Agarwal, R., Baker, J. N., Bauman, J. R., Beck, A. C., Campbell, T. C., Carey, E. C., Case, A. A., Dalal, S., Doberman, D. J., Epstein, A. S., Fecher, L., Jones, J., Kapo, J., Lee, R. T., Loggers, E. T., McCammon, S., Mitchell, W., Ogunseitan, A. B., Portman, D. G., Ramchandran, K., Sutton, L., Temel, J., Teply, M. L., Terauchi, S. Y., Thomas, J., Walling, A. M., Zachariah, F., Bergman, M. A., Ogba, N., & Campbell, M. (2021). NCCN Guidelines® Insights: Palliative Care, Version 2.2021. J Natl Compr Canc Netw, 19(7), 780-788. https://doi.org/10.6004/jnccn.2021.0033

de la Cruz, M., & Delgado-Guay, M. O. (2021). Financial toxicity in people living with advanced cancer: A new, deadly, and poorly addressed effect of cancer and necessary treatment. Semin Oncol Nurs, 37(4), 151171. https://doi.org/10.1016/j.soncn.2021.151171

Delgado-Guay, M., Ferrer, J., Rieber, A. G., Rhondali, W., Tayjasanant, S., Ochoa, J., Cantu, H., Chisholm, G., Williams, J., Frisbee-Hume, S., & Bruera, E. (2015). Financial distress and its associations with physical and emotional symptoms and quality of life among advanced cancer patients. Oncologist, 20(9), 1092-1098. https://doi.org/10.1634/theoncologist.2015-0026

Estupiñán, H. Y., Berglöf, A., Zain, R., & Smith, C. I. E. (2021). Comparative analysis of BTK inhibitors and mechanisms underlying adverse effects. Front Cell Dev Biol, 9, 630942. https://doi.org/10.3389/fcell.2021.630942

Fenn, K. M., Evans, S. B., McCorkle, R., DiGiovanna, M. P., Pusztai, L., Sanft, T., Hofstatter, E. W., Killelea, B. K., Knobf, M. T., Lannin, D. R., Abu-Khalaf, M., Horowitz, N. R., & Chagpar, A. B. (2014). Impact of financial burden of cancer on survivors’ quality of life. J Oncol Pract, 10(5), 332-338. https://doi.org/10.1200/jop.2013.001322

Fitch, M. I., & Longo, C. J. (2021). Emerging understanding about the impact of financial toxicity related to cancer: Canadian perspectives. Seminars in Oncology Nursing, 37(4), 151174. https://doi.org/https://doi.org/10.1016/j.soncn.2021.151174

Goetz, M. P., Toi, M., Campone, M., Sohn, J., Paluch-Shimon, S., Huober, J., Park, I. H., Trédan, O., Chen, S.-C., Manso, L., Freedman, O. C., Jaliffe, G. G., Forrester, T., Frenzel, M., Barriga, S., Smith, I. C., Bourayou, N., & Leo, A. D. (2017). MONARCH 3: Abemaciclib as initial therapy for advanced breast cancer. Journal of Clinical Oncology, 35(32), 3638-3646. https://doi.org/10.1200/jco.2017.75.6155

Grunfeld, E., Coyle, D., Whelan, T., Clinch, J., Reyno, L., Earle, C. C., Willan, A., Viola, R., Coristine, M., Janz, T., & Glossop, R. (2004). Family caregiver burden: Results of a longitudinal study of breast cancer patients and their principal caregivers. CMAJ, 170(12), 1795-1801. https://doi.org/10.1503/cmaj.1031205

Hagerty, R. G., Butow, P. N., Ellis, P. A., Lobb, E. A., Pendlebury, S., Leighl, N., Goldstein, D., Lo, S. K., & Tattersall, M. H. N. (2004). Cancer Patient Preferences for communication of prognosis in the metastatic setting. Journal of Clinical Oncology, 22(9), 1721-1730. https://doi.org/10.1200/jco.2004.04.095

Henley, S. J., Ward, E. M., Scott, S., Ma, J., Anderson, R. N., Firth, A. U., Thomas, C. C., Islami, F., Weir, H. K., Lewis, D. R., Sherman, R. L., Wu, M., Benard, V. B., Richardson, L. C., Jemal, A., Cronin, K., & Kohler, B. A. (2020). Annual report to the nation on the status of cancer, part I: National cancer statistics. Cancer, 126(10), 2225-2249. https://doi.org/10.1002/cncr.32802

Hollander, M. J., Liu, G., & Chappell, N. L. (2009). Who cares and how much? The imputed economic contribution to the Canadian healthcare system of middle-aged and older unpaid caregivers providing care to the elderly. Healthc Q, 12(2), 42-49. https://doi.org/10.12927/hcq.2009.20660

Hortobagyi, G. N., Stemmer, S. M., Burris, H. A., Yap, Y. S., Sonke, G. S., Paluch-Shimon, S., Campone, M., Petrakova, K., Blackwell, K. L., Winer, E. P., Janni, W., Verma, S., Conte, P., Arteaga, C. L., Cameron, D. A., Mondal, S., Su, F., Miller, M., Elmeliegy, M., Germa, C., & O’Shaughnessy, J. (2018). Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer. Ann Oncol, 29(7), 1541-1547. https://doi.org/10.1093/annonc/mdy155

Jacobsen, P. B., Nipp, R. D., & Ganz, P. A. (2017). Addressing the survivorship care needs of patients receiving extended cancer treatment. Am Soc Clin Oncol Educ Book, 37, 674-683. https://doi.org/10.14694/EDBK_175673

Lindeman, N. I., Cagle, P. T., Aisner, D. L., Arcila, M. E., Beasley, M. B., Bernicker, E. H., Colasacco, C., Dacic, S., Hirsch, F. R., Kerr, K., Kwiatkowski, D. J., Ladanyi, M., Nowak, J. A., Sholl, L., Temple-Smolkin, R., Solomon, B., Souter, L. H., Thunnissen, E., Tsao, M. S., Ventura, C. B., Wynes, M. W., & Yatabe, Y. (2018). Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology. Archives of Pathology & Laboratory Medicine, 142(3), 321-346. https://doi.org/10.5858/arpa.2017-0388-CP

Longo, C. J., Fitch, M. I., Loree, J. M., Carlson, L. E., Turner, D., Cheung, W. Y., Gopaul, D., Ellis, J., Ringash, J., Mathews, M., Wright, J., Stevens, C., D’Souza, D., Urquhart, R., Maity, T., Balderrama, F., & Haddad, E. (2021). Patient and family financial burden associated with cancer treatment in Canada: A national study. Support Care Cancer, 29(6), 3377-3386. https://doi.org/10.1007/s00520-020-05907-x

Lyons, K. D., Newman, R. M., Sullivan, M., Pergolotti, M., Braveman, B., & Cheville, A. L. (2019). Employment concerns and associated impairments of women living with advanced breast cancer. Archives of Rehabilitation Research and Clinical Translation, 1(1), 100004. https://doi.org/https://doi.org/10.1016/j.arrct.2019.100004

Majeed, U., Manochakian, R., Zhao, Y., & Lou, Y. (2021). Targeted therapy in advanced non-small cell lung cancer: Current advances and future trends. Journal of hematology & oncology, 14(1), 108-108. https://doi.org/10.1186/s13045-021-01121-2

Medicine, I. o., & Council, N. R. (2006). From cancer patient to vancer survivor: Lost in transition. The National Academies Press. https://doi.org/doi:10.17226/11468

Nasmith, L., Kupka, S., Ballem, P., & Creede, C. (2013). Achieving care goals for people with chronic health conditions. Canadian Family Physician, 59(1), 11-13. ://WOS:000314461900008

Nipp, R. D., El-Jawahri, A., Fishbein, J. N., Eusebio, J., Stagl, J. M., Gallagher, E. R., Park, E. R., Jackson, V. A., Pirl, W. F., Greer, J. A., & Temel, J. S. (2016). The relationship between coping strategies, quality of life, and mood in patients with incurable cancer. Cancer, 122(13), 2110-2116. https://doi.org/10.1002/cncr.30025

Northouse, L., Williams, A. L., Given, B., & McCorkle, R. (2012). Psychosocial care for family caregivers of patients with cancer. J Clin Oncol, 30(11), 1227-1234. https://doi.org/10.1200/jco.2011.39.5798

Nursing, C. A. o. S. o. (2020). In: Canadian Association of Schools of Nursing.

Petrillo, L. A., El-Jawahri, A., Gallagher, E. R., Jackson, V. A., Temel, J. S., & Greer, J. A. (2021). Patient-reported and end-of-life outcomes among adults with lung cancer receiving targeted therapy in a clinical trial of early integrated palliative care: A secondary analysis. J Pain Symptom Manage, 62(3), e65-e74. https://doi.org/10.1016/j.jpainsymman.2021.02.010

Rocque, G. B., Rasool, A., Williams, B. R., Wallace, A. S., Niranjan, S. J., Halilova, K. I., Turkman, Y. E., Ingram, S. A., Williams, C. P., Forero-Torres, A., Smith, T., Bhatia, S., & Knight, S. J. (2019). What is important when making teatment decisions in metastatic breast cancer? A qualitative analysis of decision-making in patients and oncologists. Oncologist, 24(10), 1313-1321. https://doi.org/10.1634/theoncologist.2018-0711

Romanelli, M., & Hudson, K. D. (2017). Individual and systemic barriers to health care: Perspectives of lesbian, gay, bisexual, and transgender adults. Am J Orthopsychiatry, 87(6), 714-728. https://doi.org/10.1037/ort0000306

Rugo, H. S., Finn, R. S., Diéras, V., Ettl, J., Lipatov, O., Joy, A. A., Harbeck, N., Castrellon, A., Iyer, S., Lu, D. R., Mori, A., Gauthier, E. R., Bartlett, C. H., Gelmon, K. A., & Slamon, D. J. (2019). Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up. Breast Cancer Res Treat, 174(3), 719-729. https://doi.org/10.1007/s10549-018-05125-4

Sciences:, R. o. t. E. P. a. b. t. C. A. o. H. (2010). Transforming care for Canadians with chronic health conditions: Put people first, expect the best, manage for results. Ottawa Ontario: Canadian Academy of Health Sciences https://www.cahs-acss.ca/wp-content/uploads/2011/09/cdm-final-English.pdf

Shankaran, V., Leahy, T., Steelquist, J., Watabayashi, K., Linden, H., Ramsey, S., Schwartz, N., Kreizenbeck, K., Nelson, J., Balch, A., Singleton, E., Gallagher, K., & Overstreet, K. (2018). Pilot feasibility study of an oncology financial navigation program. Journal of Oncology Practice, 14(2), e122-e129. https://doi.org/10.1200/jop.2017.024927

Stergiou-Kita, M., Pritlove, C., van Eerd, D., Holness, L. D., Kirsh, B., Duncan, A., & Jones, J. (2016). The provision of workplace accommodations following cancer: Survivor, provider, and employer perspectives. J Cancer Surviv, 10(3), 489-504. https://doi.org/10.1007/s11764-015-0492-5

Temel, J. S., Greer, J. A., Muzikansky, A., Gallagher, E. R., Admane, S., Jackson, V. A., Dahlin, C. M., Blinderman, C. D., Jacobsen, J., Pirl, W. F., Billings, J. A., & Lynch, T. J. (2010). Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med, 363(8), 733-742. https://doi.org/10.1056/NEJMoa1000678

Watabayashi, K., Steelquist, J., Overstreet, K. A., Leahy, A., Bradshaw, E., Gallagher, K. D., Balch, A. J., Lobb, R., Lavell, L., Linden, H., Ramsey, S. D., & Shankaran, V. (2020). A pilot study of a comprehensive financial navigation program in patients with cancer and caregivers. J Natl Compr Canc Netw, 18(10), 1366-1373. https://doi.org/10.6004/jnccn.2020.7581

Young, A. M., Charalambous, A., Owen, R. I., Njodzeka, B., Oldenmenger, W. H., Alqudimat, M. R., & So, W. K. W. (2020). Essential oncology nursing care along the cancer continuum. Lancet Oncol, 21(12), e555-e563. https://doi.org/10.1016/s1470-2045(20)30612-4


Refbacks

  • There are currently no refbacks.